In the mitogen activated protein kinase pathway, the activation of RAS is counteracted by-
**Core Concept**
The mitogen-activated protein kinase (MAPK) pathway, also known as the Ras-Raf-MEK-ERK pathway, is a crucial signaling cascade involved in cellular proliferation, differentiation, and survival. Activation of the RAS protein is a key step in this pathway, but it must be tightly regulated to prevent uncontrolled cell growth and tumorigenesis.
**Why the Correct Answer is Right**
The activation of RAS is counteracted by the GTPase-activating protein (GAP) complex, which consists of RASGAP and NF1. These proteins bind to RAS and stimulate its GTPase activity, leading to the hydrolysis of GTP to GDP and the inactivation of RAS. This negative feedback loop is essential for maintaining the balance of RAS activity and preventing aberrant cell growth.
**Why Each Wrong Option is Incorrect**
**Option A:** NF1 is a tumor suppressor gene that encodes a protein that binds to RAS and prevents its activation, but it is not directly involved in the counteraction of RAS activation.
**Option B:** RAF is a downstream effector of RAS, but it is not responsible for counteracting RAS activation.
**Option C:** MEK is another downstream effector of RAS, but it also does not counteract RAS activation.
**Clinical Pearl / High-Yield Fact**
The MAPK pathway is frequently dysregulated in various cancers, including melanoma, colorectal cancer, and lung cancer. Understanding the negative feedback mechanisms that regulate RAS activity is crucial for developing targeted therapies for these diseases.
**Correct Answer:** D. GTPase-activating protein (GAP) complex